Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

AMEDS-PMHS - part one

413 views

Published on

  • Be the first to comment

  • Be the first to like this

AMEDS-PMHS - part one

  1. 1. AMEDS - PMHS<br />Innovation<br />for<br />Cure and Care<br />
  2. 2. AMEDS - PMHS<br />SystiMed is anenterprisefordesigning and developinginnovationsforhealthcare<br />These presentations are abouttwo brand newinnovationsdesignedby SystiMed<br />In thisfirst part a verylargeproblem in todayshealthcare is outlined<br />In the second part the innovations AMEDS and PMHS willbepresented<br />
  3. 3. AMEDS - PMHS<br />AMEDS - PMHS<br />Part one<br />
  4. 4. AMEDS - PMHS<br />Do you want to know more aboutone of the biggestchallenges we face in healthcaretoday?<br />
  5. 5. AMEDS – PMHS<br />Do you want to know more aboutone of the biggestchallenges we face in healthcaretoday?<br />Ifso, thenplease, readon and learnabout a mechanismwhichcan have a dominatingnegativeinfluenceonhealthcareformanyyears to come.<br />
  6. 6. AMEDS - PMHS<br />Medicationadherence has been a very big problem in healthcarefor a long time<br />
  7. 7. AMEDS - PMHS<br />Medicationadherence has been a very big problem in healthcarefor a long time<br />and still is…<br />
  8. 8. AMEDS - PMHS<br />Medicationadherence has been a very big problem in healthcarefor a long time<br />and still is…<br />Severaltechnicalsollutions have been introduced to help patientstaketheirmedication, like the Baxter system, the Simpill, the Medido (Innospense) and recently the PicoBello (Kysos). <br />
  9. 9. AMEDS - PMHS<br />Althoughcurrenttechnicalsollutionsformedicationadherencecanbeverysuccesfullforsomepatients…..<br />
  10. 10. AMEDS - PMHS<br />Althoughcurrenttechnicalsollutionsformedicationadherencecanbeverysuccesfullforsomepatients…..<br />there are still a lot of patientswho in spite of the usage of these technicalsollution are stillnotable to taketheirmedicationadequately<br />
  11. 11. AMEDS - PMHS<br />Unfortunately….<br />
  12. 12. AMEDS - PMHS<br />Unfortunately these are the most vulnerable, fragile, elderlypatients.<br />
  13. 13. AMEDS - PMHS<br />Unfortunately these are the most vulnerable, fragile, elderlypatients.<br />These elderlypatients have severalseriousillnesses (multimorbidity)<br />
  14. 14. AMEDS - PMHS<br />Unfortunately these are the most vulnerable, fragile, elderlypatients.<br />These elderlypatients have severalseriousillnesses (multimorbidity)<br />and need to take a largenumber of different sorts of medicines eachday (polypharmacy) <br />
  15. 15. AMEDS - PMHS<br />The largenumber of illnesses these elderlypatients have result in cognitive and physicalshortcomings<br />
  16. 16. AMEDS - PMHS<br />The largenumber of illnesses these elderlypatients have result in cognitive and physicalshortcomings<br />These shortcomingscanalsojustbeagerelated<br />
  17. 17. AMEDS - PMHS<br />These cognitive and physicalshortcomingsinterferewith the dailyfunctioning of these elderlypatients<br />
  18. 18. AMEDS - PMHS<br />These cognitive and physicalshortcomingsinterferewith the dailyfunctioning of these elderlypatients<br />Thisincludestakingmedication<br />
  19. 19. AMEDS - PMHS<br />These cognitive and physicalshortcomingsinterferewith the dailyfunctioning of these elderlypatients<br />Thisincludestakingmedication<br />Thisleads to socalledmedication nonadherence by these patients<br />
  20. 20. AMEDS - PMHS<br />So, thiscategory of elderlypatients have the intention to taketheirmedicine<br />
  21. 21. AMEDS - PMHS<br />So, thiscategory of elderlypatients have the intention to taketheirmedicine<br />butthey are notable to do so, because of shortcomingsdue to illnessesoroldage.<br />
  22. 22. AMEDS - PMHS<br />So, thiscategory of elderlypatients have the intention to taketheirmedicine<br />butthey are notable to do so, because of shortcomingsdue to illnessesoroldage.<br />We callthis a form of …<br />
  23. 23. AMEDS - PMHS<br />So, thiscategory of elderlypatients have the intention to taketheirmedicine<br />butthey are notable to do so, because of shortcomingsdue to illnessesoroldage.<br />We callthis a form of …<br />‘nonintentional medication nonadherence’<br />
  24. 24. AMEDS - PMHS<br />Especiallywith these elderly, vulnerablepatientsmedication nonadherence is highlyunwanted…. <br />
  25. 25. AMEDS - PMHS<br />Especiallywith these elderly, vulnerablepatientsmedication nonadherence is highlyunwanted…. <br />buthighlylikely<br />
  26. 26. AMEDS - PMHS<br />Especiallywith these elderly, vulnerablepatientsmedication nonadherence is highlyunwanted…. <br />buthighlylikely<br />and with these fragile and vurnerableolderpatients even the slightestmedication nonadherence can have serious, and sometimesdevastatingeffects!<br />
  27. 27. AMEDS - PMHS<br />Question:<br />
  28. 28. AMEDS - PMHS<br />Question: What are the effects of medication nonadherence with these fragile, vulnerablepatients?<br />
  29. 29. AMEDS - PMHS<br />Question: What are the effects of medication nonadherence with these fragile, vulnerablepatients?<br />Answer:<br />
  30. 30. AMEDS - PMHS<br />Question: What are the effects of medication nonadherence with these fragile, vulnerablepatients?<br />Answer:<br />Longterm hospitaladmissions<br />
  31. 31. AMEDS - PMHS<br />Question: What are the effects of medication nonadherence with these fragile, vulnerablepatients?<br />Answer:<br />Longterm hospitaladmissions<br />Deterioration of patientshealth<br />
  32. 32. AMEDS - PMHS<br />Question: What are the effects of medication nonadherence with these fragile, vulnerablepatients?<br />Answer:<br />Longterm hospitaladmissions<br />Deterioration of patientshealth<br />Need of superimposedtreatments<br />
  33. 33. AMEDS - PMHS<br />Question: What are the effects of medication nonadherence with these fragile, vulnerablepatients?<br />Answer:<br />Longterm hospitaladmissions<br />Deterioration of patientshealth<br />Need of superimposedtreatments<br />More need of elderly care<br />
  34. 34. AMEDS - PMHS<br />Question: What are the effects of medication nonadherence with these fragile, vulnerablepatients?<br />Answer:<br />Longterm hospitaladmissions<br />Deterioration of patientshealth<br />Need of superimposedtreatments<br />More need of elderly care<br />Admissions in elderly homes<br />
  35. 35. AMEDS - PMHS<br />Question: What are the effects of medication nonadherence with these fragile, vulnerablepatients?<br />Answer:<br />Longterm hospitaladmissions<br />Deterioration of patientshealth<br />Need of superimposedtreatments<br />More need of elderly care<br />Admissions in elderly homes<br />Death<br />
  36. 36. AMEDS - PMHS<br />To beable to help these patients to taketheirdailypillsadequately<br />
  37. 37. AMEDS - PMHS<br />To beable to help these patients to taketheirdailypillsadequately<br />a muchbettertechnical support is needed!<br />
  38. 38. AMEDS - PMHS<br />To beable to help these patients to taketheirdailypillsadequately<br />a muchbettertechnical support is needed!<br />Muchbetterthancanbeprovidedwith the currentsystems<br />
  39. 39. AMEDS - PMHS<br />In case a technicalapropriatesollutioncannotbefound, the onlyalternative to help these patients is by hand, which has its drawbacks:<br />
  40. 40. AMEDS - PMHS<br />In case a technicalapropriatesollutioncannotbefound, the onlyalternative to help these patients is by hand, which has its drawbacks:<br />A largenumber of healthcare professionals are needed to performthistedious service.<br />
  41. 41. AMEDS - PMHS<br />In case a technicalapropriatesollutioncannotbefound, the onlyalternative to help these patients is by hand, which has its drawbacks:<br />A largenumber of healthcare professionals are needed to performthistedious service.<br />Helping these patientsby hand in this respect induceshumanerrors and bythismedication nonadherence.<br />
  42. 42. AMEDS - PMHS<br />In case a technicalapropriatesollutioncannotbefound, the onlyalternative to help these patients is by hand, which has its drawbacks:<br />A largenumber of healthcare professionals are needed to performthistedious service.<br />Helping these patientsby hand in this respect induceshumanerrors and bythismedication nonadherence.<br />The patients are becomingtoomuchdependent<br />
  43. 43. AMEDS – PMHS<br />So, helping these patientstakingtheirpillspreferablywith a technicalsollution is of greatimportance!<br />
  44. 44. AMEDS – PMHS<br />So, helping these patientstakingtheirpillspreferablywith a technicalsollution is of greatimportance!<br />As in countrieswhich face a verylargeupcomingincrease of the numbers of elderlypeople<br />
  45. 45. AMEDS – PMHS<br />So, helping these patientstakingtheirpillspreferablywith a technicalsollution is of greatimportance!<br />As in countrieswhich face a verylargeupcomingincrease of the numbers of elderlypeople<br />the number of thiscategory of patientswillbecomealsoverylarge. <br />
  46. 46. AMEDS - PMHS<br />Impact of the increase in numbers of these elderlyfragile, vulnerablepatientswho are notable to taketheirmedication:<br />
  47. 47. AMEDS - PMHS<br />Impact of the increase in numbers of these elderlyfragile, vulnerablepatientswho are notable to taketheirmedication:<br />Largeincrease of healthcarecosts.<br />
  48. 48. AMEDS - PMHS<br />Impact of the increase in numbers of these elderlyfragile, vulnerablepatientswho are notable to taketheirmedication:<br />Largeincrease of healthcarecosts.<br />Severeshortage of healthcare professionals to copewith the increasedworkload.<br />
  49. 49. AMEDS - PMHS<br />Question:<br />
  50. 50. AMEDS - PMHS<br />Question: whatcosts are involved?<br />
  51. 51. AMEDS - PMHS<br />Question: whatcosts are involved?<br />Answer:<br />
  52. 52. AMEDS - PMHS<br />Question: whatcosts are involved?<br />Answer:<br />In the Netherlands the totalcostsinvolvedwithmedicationadherence are ca. 1 billion Euro a year.<br />
  53. 53. AMEDS - PMHS<br />Question: whatcosts are involved?<br />Answer:<br />In the Netherlands the totalcostsinvolvedwithmedicationadherence are ca. 1 billion Euro a year<br />In the US the totalcostsinvolvedwithmedicationadherence are ca. 300 billion USD a year (!)<br />
  54. 54. AMEDS - PMHS<br />
  55. 55. AMEDS - PMHS<br />Answercontinued:<br />
  56. 56. AMEDS - PMHS<br />Answercontinued:<br />Although the mentionedtotalcostsdue to medicationadherenceseemvery high…<br />
  57. 57. AMEDS - PMHS<br />Answercontinued:<br />Although the mentionedtotalcostsdue to medicationadherenceseemvery high…<br />it is stillunclearhowmuch the mentionedcategory of patientstribute to these costs<br />
  58. 58. AMEDS - PMHS<br />Answercontinued:<br />Although the mentionedtotalcostsdue to medicationadherenceseemvery high…<br />it is stillunclearhowmuch the mentionedcategory of patientstribute to these costs<br />Butitmightbevery high!<br />
  59. 59. AMEDS - PMHS<br />Answercontinued:<br />Although the mentionedtotalcostsdue to medicationadherenceseemvery high…<br />it is stillunclearhowmuch the mentionedcategory of patientstribute to these costs<br />Butitmightbevery high!<br />And these costsmighteasilyskyrocketthe coming years!<br />
  60. 60. AMEDS - PMHS<br />Answercontinued:<br />
  61. 61. AMEDS - PMHS<br />Answercontinued:<br />And costs are not even the biggest issue here<br />
  62. 62. AMEDS - PMHS<br />Answercontinued:<br />And costs are not even the biggest issue here<br />The biggestproblem we face here is that we won’tbeable to provide the healthcareprofesionalsneeded to care for these patients - and otherpatients – anymore.<br />
  63. 63. AMEDS - PMHS<br />Question:<br />
  64. 64. AMEDS - PMHS<br />Question: how is itthatcurrent system fall short of helping these oldpeopletaketheirmedicationadequately?<br />
  65. 65. AMEDS - PMHS<br />Question: how is itthatcurrent system fall short of helping these oldpeopletaketheirmedicationadequately?<br />Answer:<br />
  66. 66. AMEDS - PMHS<br />Question: how is itthatcurrent system fall short of helping these oldpeopletaketheirmedicationadequately?<br />Answer: unfortunately these currentsystemsfall short heremainlyontwoessentialaspects: <br />
  67. 67. AMEDS - PMHS<br />Question: how is itthatcurrent system fall short of helping these oldpeopletaketheirmedicationadequately?<br />Answer: unfortunately these currentsystemsfall short heremainlyontwoessentialaspects: <br />Ergonomic design<br />
  68. 68. AMEDS - PMHS<br />Question: how is itthatcurrent system fall short of helping these oldpeopletaketheirmedicationadequately?<br />Answer: unfortunately these currentsystemsfall short heremainlyontwoessentialaspects: <br />Ergonomic design<br />Multi-userfriendlyness<br />
  69. 69. AMEDS – PMHS<br />Ergonomic design:<br />
  70. 70. AMEDS – PMHS<br />Ergonomic design: Most currentsystems are someform of pillboxes, baxter systems (Medido, PicoBello) whichworkwithpillbagsorpill cups (MD.2; Philips); someexamples:<br />
  71. 71. AMEDS – PMHS<br />Ergonomic design: Most currentsystems are someform of pillboxes, baxter systems (Medido, PicoBello) whichworkwithpillbagsorpill cups (MD.2; Philips); someexamples:<br />A patientwith a hemiparalysis and apraxiadue to a strokestruggles to getpills out of a plastic bagsuppliedby a Baxter system; the patientunfortunately is notable to do this and justthrowsaway the full bag.<br />
  72. 72. AMEDS – PMHS<br />Ergonomic design: Most currentsystems are someform of pillboxes, baxter systems (Medido, PicoBello) whichworkwithpillbagsorpill cups (MD.2; Philips); someexamples:<br />A patientwith a hemiparalysis and apraxiadue to a strokestruggles to getpills out of a plastic bagsuppliedby a Baxter system; the patientunfortunately is notable to do this and justthrowsaway the full bag.<br />A patientwith a tremor due to Parkinsontries to gethispillsfrom a MD.2- cup, due to the tremor all pillsfallon the floor.<br />
  73. 73. AMEDS - PMHS<br />Multi-userfriendlyness:<br />
  74. 74. AMEDS - PMHS<br />Multi-userfriendlyness: currentsystemsdesignedforreducingmedication nonadherence are mostlyuser-friendlyforonlyonegroupinvolved, someexamples:<br />
  75. 75. AMEDS - PMHS<br />Multi-userfriendlyness: currentsystemsdesignedforreducingmedication nonadherence are mostlyuser-friendlyforonlyonegroupinvolved, someexamples:<br />The Baxter system orderrivativeslike the MedidoorPicoBello are veryuser-friendlyfor the pharmacist, unfortunatelynotfor all patients.<br />
  76. 76. AMEDS - PMHS<br />Multi-userfriendlyness: currentsystemsdesignedforreducingmedication nonadherence are mostlyuser-friendlyforonlyonegroupinvolved, someexamples:<br />The Baxter system orderrivativeslike the MedidoorPicoBello are veryuser-friendlyfor the pharmacist, unfortunatelynotfor all patients.<br />The MD.2 (Philips) mightbeuser-friendlyforsomepatients, but is veryuser-unfriendlyfor the pharmacist, as the pharmacist is bound to fill all cups by hand.<br />
  77. 77. AMEDS - PMHS<br />Question:<br />
  78. 78. AMEDS - PMHS<br />Question: so, with all this in the back of ourhead, what do we want for these elderly, fragile, vulnerablepatients?<br />
  79. 79. AMEDS - PMHS<br />Question: so, with all this in the back of ourhead, what do we want for these elderly, fragile, vulnerablepatients?<br />Answer:<br />
  80. 80. AMEDS - PMHS<br />Question: so, with all this in the back of ourhead, what do we want for these elderly, fragile, vulnerablepatients?<br />Answer: to support these patients we need a system which combines the followingattributes:<br />
  81. 81. AMEDS - PMHS<br />Question: so, with all this in the back of ourhead, what do we want for these elderly, fragile, vulnerablepatients?<br />Answer: to support these patients we need a system which combines the followingattributes:<br />Muli-userfriendlyness<br />
  82. 82. AMEDS - PMHS<br />Question: so, with all this in the back of ourhead, what do we want for these elderly, fragile, vulnerablepatients?<br />Answer: to support these patients we need a system which combines the followingattributes:<br />Muli-userfriendlyness<br />Optimalergonomic design<br />
  83. 83. AMEDS - PMHS<br />Question: so, with all this in the back of ourhead, what do we want for these elderly, fragile, vulnerablepatients?<br />Answer: to support these patients we need a system which combines the followingattributes:<br />Muli-userfriendlyness<br />Optimalergonomic design<br />Safety in usage<br />
  84. 84. AMEDS - PMHS<br />Question: so, with all this in the back of ourhead, what do we want for these elderly, fragile, vulnerablepatients?<br />Answer: to support these patients we need a system which combines the followingattributes:<br />Muli-userfriendlyness<br />Optimalergonomic design<br />Safety in usage<br />Reliability in usage<br />
  85. 85. AMEDS - PMHS<br />Ifyou want to knowhow a system with all these attributescanbedesigned, keep on the look out herefor the upcomingpresentation of AMEDS and PMHS<br />
  86. 86. AMEDS - PMHS<br />Ifyou want to knowhow a system with all these attributescanbedesigned, keep on the look out herefor the upcomingpresentation of AMEDS and PMHS<br />In the meantime….<br />
  87. 87. AMEDS - PMHS<br />Ifyou want to knowhow a system with all these attributescanbedesigned, keep on the look out herefor the upcomingpresentation of AMEDS and PMHS<br />In the meantime….<br />Try and design a system likethatyourself!<br />
  88. 88. AMEDS – PMHS<br />Thankyou<br />

×